Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CORT: Corcept Therapeutics Incorporated Stock Analysis | finqOS
Healthcare · Medical - Pharmaceuticals
The Story
CORT
The Story
CORT
Loading chart data...
Current State
Balance holding
The verdict
Good business
No data
Operating margin
0.8%
ROIC
0.9%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
2.86×
Valuation
Unrated
P/E ratio
220.2×
Corcept Therapeutics Incorporated
CORT
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Corcept Therapeutics Incorporated
CORT
NASDAQ
·
USD
·
Closed
$114.49
−3.24%
$114.49
−$3.83 (3.24%)
52W Range
92th
pctl
Volume
1.50×
avg
Mkt Cap
12.38B
USD
P/E
220.2
TTM
Div Yield
–
ann
52W Range
92th
pctl
Volume
1.50×
avg
Market Cap
12.38B
USD
P/E Ratio
220.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings